NCT04189003View on ClinicalTrials.gov

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Oropharyngeal CancerHuman Papillomavirus-Related Carcinoma
Trial Locations (1)

75015

Hôpital Européen Georges Pompidou, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04189003 - Molecular Signatures of HPV+ ORL Cancers (OROPAP) | Biotech Hunter | Biotech Hunter